P & G Health Ltd

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,689.90
32 (0.57%)
BSENSE

Sep 07, 03:50 PM

BSE+NSE Vol: 5.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Jun'24
Jun'23
Jun'22
Jun'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025

Compare Profit and Loss Results of P & G Health Ltd
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,407.00
878.00
529.00
60.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,407.00
878.00
529.00
60.25%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
0.00
-12.00
0%
Raw Materials Consumed
377.00
230.00
147.00
63.91%
Power & Fuel Cost
7.00
0.00
7.00
0%
Employee Cost
222.00
128.00
94.00
73.44%
Operating Expenses
90.00
52.00
38.00
73.08%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
106.00
95.00
11.00
11.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
21.00
12.00
9.00
75.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
951.00
569.00
382.00
67.14%
Operating Profit (PBDIT) excl Other Income
456.00
309.00
147.00
47.57%
Other Income
17.00
18.00
-1.00
-5.56%
Operating Profit (PBDIT)
474.00
327.00
147.00
44.95%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
473.00
325.00
148.00
45.54%
Depreciation
23.00
11.00
12.00
109.09%
Profit Before Taxation & Exceptional Items
449.00
313.00
136.00
43.45%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
449.00
320.00
129.00
40.31%
Provision for Tax
122.00
80.00
42.00
52.50%
Profit After Tax
326.00
240.00
86.00
35.83%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
159.00
229.00
-70.00
-30.57%
Profit Available for appropriations
486.00
469.00
17.00
3.62%
Appropriations
486.00
469.00
17.00
3.62%
Equity Dividend (%)
2050%
750%
1,300.00
Earnings Per Share
197
104.27
92.73
88.93%
Profit And Loss - Net Sales
Net Sales 1,407.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 326.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025